CEF8, Influenza Virus NP, Inhibitor | CEF8, inhibitor

CEF8, Influenza Virus NP 383-391

Cat. Num. AAA5765409

• Purity: 0.9974
• Synonyms: CEF8; Influenza Virus NP; Influenza Virus NP 383-391; inhibitor

• Purity/Purification: 0.9974
• Form/Format: Solid

• Solubility: (<1mg/ml refers to the product slightly soluble or insoluble)
• SMILES: N=C(N)NCCC[C@@H](C(O)=O)NC([C@H]([C@H](O)C)NC([C@H](CCCNC(N)=N)NC([C@H]([C@@H](C)CC)NC([C@H](C)NC([C@H](CC1=CNC2=C1C=CC=C2)NC([C@H](CC3=CC=C(O)C=C3)NC([C@H](CCCNC(N)=N)NC([C@H](CO)N)=O)=O)=O)=O)=O)=O)=O)=O
• Formula: C54H85N19O13
• CAS Number: 142479-13-8
• Preparation and Storage: Store at 0-4 degree C for short term (days to weeks), or -20 degree C for long term (months).

Chemical Structure

Related Product Information for CEF8, inhibitor

CEF8,Influenza Virus NP 383-391 is an influenza A virus nucleoprotein containing residues 383 to 391,is the most important HLA-B*2705-restricted epitope in the nucleoprotein of influenza A viruses and is associated with escape from cytotoxic T lymphocytes-mediated immunity.HLA-B*3501 restricted influenza virus nucleoprotein epitope (383-391).

Product Categories/Family for CEF8, inhibitor

Others

References

Berkhoff EG, et al. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol. 2004 May;78(10):5216-22.